Home > Pharmaceuticals > Cancer Microbiome Sequencing Market Segmentation, Demand, Forecast to 2030
Straits Research

Cancer Microbiome Sequencing Market

Cancer Microbiome Sequencing Market: Information by Offering (Product, Service), End-User (Hospitals and Diagnostic Laboratories), and Region — Forecast till 2030

Table of Content Download Sample

Market Overview

The global cancer microbiome sequencing market was valued at USD 185.8 million in 2021 and is projected to reach USD 953 million by 2030, registering a CAGR of 19.92% from 2022 to 2030.

A collection of bacteria that live in and on the human body is referred to as the human microbiome. These bacteria have the potential to affect the initiation, progression, and treatment response of cancer, including cancer immunotherapy. The influence of microbiomes on cancer could result in the development of new diagnostic and treatment methods. It establishes the parameters of the market for sequencing the cancer microbiome. The rising awareness of the potential of the microbiome to play a role in the treatment of cancer, the rising prevalence of cancer around the world, and the falling cost of sequencing are the three primary factors that are driving this industry.

Market Snapshot

market snapshot
Base Year
: 2021
Study Period
: 2020-2030
: 19.92 %
Fastest Growing Market
: Asia Pacific
Largest Market
: North America
Market Size
: 953
Get more information on this report Download Sample Report

Market Dynamics

Global Cancer Microbiome Sequencing Market Drivers

  • The global increase in cancer prevalence

The sequencing of cancer microbiomes is experiencing a boom right now as a result of a number of factors, including the growing awareness of the role that the microbiome could play in the treatment of cancer, the rising incidence of cancer around the world, and the falling cost of sequencing. Additionally, biotechnology companies are concentrating their efforts on developing cancer microbiome sequencing solutions for applications such as translational research and diagnostics. This will provide researchers and clinicians with additional support in their efforts to uncover insights regarding the microbiome's influence on the manifestation and progression of cancer.

Global Cancer Microbiome Sequencing Market Restraints

  • Lack of High Complexity Testing Centers

The expansion of the market is being hampered by the absence of high-complexity testing centres, particularly in the emerging and developing nations of Asia Pacific, the Middle East, and Africa.

The situation will get better in the future thanks to increased per capita income as well as increased government investment in this area.

Global Cancer Microbiome Sequencing Market Opportunity

  • Focus on development

The development of reliable cancer microbiome sequencing solutions for applications such as diagnostics and translational research is currently a primary focus of companies in the biotechnology industry. These solutions are intended to provide additional assistance to end-users in their efforts to learn more about the complexities associated with the role of human microbiomes in the manifestation and progression of cancer. In the approaching years, it is anticipated that the development of cancer microbiome sequencing products and services by the companies in conjunction with research institutes would provide value-based care to cancer patients, which will generate an opportunity for market expansion.

Segmental Analysis

By End User, the market for academic and research institutes is estimated to grow at the highest CAGR during the forecast period

By End User, In the year 2020, hospitals and diagnostic laboratories held the lion's share of the market due to the highest number of sequencing tests that were carried out in laboratories to diagnose a variety of disorders. On the other hand, it appears that academics and research will have the most rapid expansion between the years 2022 and 2030. This occurs as a result of an increase in the number of studies conducted to obtain information regarding the microbiome on a level that is more complicated.

Regional Analysis

The market is split by region into North America, Europe, Asia-Pacific, and LAMEA.

Due to the presence of market leaders such as Illumina, Inc. in the United States, as well as the significant adoption of high-fidelity cancer microbiome sequencing products and services for translational research, North America holds the largest share of the market for cancer microbiome sequencing when broken down by region. Additionally, increased financial infusions by federal entities as well as increasing investments for product development, amongst other factors. Aside from this, it is projected that growth in the Asia-Pacific area would occur at the highest CAGR throughout the course of the forecast period (2022-2030). This can be largely due to the underlying factors, which include an increase in healthcare knowledge, a stable economy that has led to a greater concentration on research, and the widespread adoption of improved cancer diagnostics, amongst other things.

Cancer Microbiome Sequencing Market Regional Analysis
Regional Growth Insights Download Free Sample

Top Key Players of Cancer Microbiome Sequencing Market

Some major players are

  1. Novogene Corporation
  2. Psomagen
  3. PerkinElmer Genomics
  4. Illumina
  5. Thermo Fisher Scientific
  6. Viome
  7. Invivo Diagnostics
  8. Zymo Research Corp
  9. Metabiomics.

Report Scope

Report Metric Details
CAGR 19.92%
Forecast Period 2023-2031
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered
    By Offering
    1. Product
      1. Kits
      2. Assays
      3. Software
    2. Service
  1. By Application
    1. Translational Research and Diagnostics
      1. Colorectal Cancer
      2. Cervical Cancer
      3. Oral Cancer
      4. Other Cancer Types
  2. By Technology
    1. Next-Generation Sequencing
      1. Sequencing by Synthesis
      2. Sequencing by Ligation
      3. Other Next-Generation Sequencing Technologies
    2. Polymerase Chain Reaction
  3. By End-User
    1. Academic and Research Institutes
    2. Pharmaceutical and Biotechnology Companies
    3. Hospitals and Diagnostic Laboratories
Geographies Covered
  • North America
  • Europe
  • APAC
  • Middle East and Africa

Recent Developments

There have been no developments in the cancer microbiome sequencing market in the last 5 years.

Cancer Microbiome Sequencing Market Segmentation

By Offering

  • Product
    • Kits
    • Assays
    • Software
  • Service

By Application

  • Translational Research and Diagnostics
    • Colorectal Cancer
    • Cervical Cancer
    • Oral Cancer
    • Other Cancer Types

By Technology

  • Next-Generation Sequencing
    • Sequencing by Synthesis
    • Sequencing by Ligation
    • Other Next-Generation Sequencing Technologies
  • Polymerase Chain Reaction

By End-User

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Diagnostic Laboratories
Price Starts From
USD 995

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report
Want to learn more about recent trends and data ?
They Already Trust Us :
Nippon Becton Dickinson
Argon Medical Devices
Johnson & Johnson
Need Assistance?
+1 646 480 7505 (U.S.)
+44 208 068 9665 (U.K.)

Report Benefits

  • Develop business strategies by understanding the trends shaping and driving the Market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track sales in the global and country-specific Market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Report Snapshot
Looking For Custom Report ?
Check Our License Options :

As featured on :

Trusted by Fortune 500
Over 30000+ subscribers